Cardiovascular Innovation Forum at VBEF 2025: Bridging Industry, Academia, and Clinical Practice to Tackle Key Challenges and Seize Opportunities
The cardiovascular sector is currently facing a dual challenge: on one end, volume-based procurement policies are reshaping the industrial ecosystem; on the other, upstream core materials and high-end equipment remain constrained by critical technological bottlenecks. To achieve genuine localization, it is essential to establish a collaborative innovation system integrating industry, academia, research, and clinical practice—from basic research to clinical translation. Breakthroughs in any single link alone are insufficient to support a complete industrial closed loop.
To foster the innovative development of industry, academia, and research in cardiovascular disease in China, and to further unlock the value of Chinese innovations,VCBeat will host the “Cardiovascular Disease Industry-Research Innovation Forum” at the 2025 VBEF Top 100 Future Healthcare and Medicine Exhibition (VBEF), to be held at the Suzhou International Expo Center on May 9., inviting national clinical cardiovascular experts, academic leaders, leading cardiovascular device manufacturers, device CROs, and frontline investors to attend.
(Information statistics as of April 1; agenda will be updated progressively)
For “industry-academia-research” assets in cardiovascular devices, go to VCBeat VBEF
Industry, academia, research, healthcare, and investment leaders convene for direct interaction among “technology–capital–market” resources
Shen Li, Secretary-General of the China Cardiovascular Physicians Innovation Club (CCI) and Chief Physician in the Department of Cardiology at Zhongshan Hospital, Fudan UniversityOn-site sharing of the clinical-driven model in the field of cardiovascular medicine,Fan Weidong, Chief Physician of the Department of Cardiology at Henan Provincial Chest HospitalExploring Innovation Opportunities in Cardiovascular Devices from a Clinical Perspective.
Capital side,Yuansheng Ventures, Nuoyu Capital, Proxima Ventures, Yuanhe OriginFront-line investors from institutions such as VCBeat share their investment logic in the cardiovascular device sector.
On the industry side,Puchuang Medical, Peixin Technology, Kaici Medical, Tonghe Litai, Baisaifei BiotechDelivering Thematic Presentations to Showcase the Innovative Power of China’s Domestic Industry Chain.
Industry, academia, research, medical, and investment leaders preside, enabling direct interaction among “technology–capital–market” resources
The forum centered on the theme of “industry-academia-research collaboration” to identify key elements and pathways for source innovation in cardiovascular devices. It shared insights on uncovering clinical needs, addressing commercialization challenges, defining directions for technological innovation, and navigating regulatory approvals within the context of integrated industry-research trends, providing valuable references for the sector.
Industrial Chain + Supply Chain: Driving Efficient Collaboration Among Medical Device Stakeholders
To foster in-depth exchange and collaboration among all stakeholders in the cardiovascular device industry and supply chains, VCBeat VBEF will concurrently host a series of N+ activities, including closed-door government-enterprise meetings, premium asset promotion sessions, and innovative product launch events.By leveraging the integrated “exhibition + forum + transaction” model, we facilitate deep connections between high-quality assets and global capital, local industrial chains, and end-user medical institutions, thereby empowering China’s innovative healthcare and pharmaceutical assets to bridge the gap from “innovation capability” to “productive capacity.”
The exhibition facilitates diversified matchmaking:2025 VBEF Special Design in the Exhibition AreaCentral Stage (Themed Roadshows, Product Launches), Innovative Product Showcase (Product Demonstrations, Case Studies)、Innovative Assets Poster Exhibition (Top 100 Investment Landscape, Resource Matchmaking)Three Major Value Domains: Accelerating the Value Fission of High-Quality Assets in China’s Medical and Pharmaceutical Innovation Through Innovative Models and Efficient Mechanisms.
Forum Decoding Trends:2 Main Forums, 4 Featured Forums, and 20+ Thematic Forums comprehensively cover the hot tracks of high-quality innovative assets in China’s healthcare and pharmaceutical sectors. Over 300 industry leaders, academicians, experts, and corporate executives discuss growth poles in China’s healthcare industry, precisely identifying growth drivers for high-quality assets.
High-Efficiency Transaction Scenarios:Exhibiting companies can engage directly with international buyers, overseas distributors, and supply chain partners. Through on-site negotiations and demand-matching sessions, they can quickly secure business opportunities in cross-border cooperation, technology introduction, and product distribution, thereby facilitating the integration of China’s high-quality innovative medical and pharmaceutical assets into the global industrial chain.
Welcome to All Industry Partners for Registration, engage in direct communication and partnership negotiations with innovative enterprises.
Free tickets available—limited quantity, first come, first served!
Share this article/poster to your WeChat Moments and collect 18 likes,
Add the Organizing Committee (Note: Ticket Benefits),
Get a ticket worth 399 yuan (excluding meals)!
Organizing Committee - Ms. Jing
Exhibition Name:2025 VBEF Future Healthcare & Pharma Top 100 Expo
Exhibition Time:May 9–10, 2025
Exhibition Venue:China · Suzhou · International Expo Center
Exhibition Scale:16,000+ patient visits
(More partners to be confirmed; stay tuned to VBEF for the latest updates.)
Host Organization:VCBeat
Co-organized by:Artery New Medicine, ATLATL Innovation Center, Enshe Family Office, Dr. Fang, Guoke Hengtai, He Eye Hospital, JD Health, Health Growth Society, Niukou Capital, Tanshen Capital, China Eye Valley, Eye Valley Select
Supporting Organizations of the Forum:MathWorks, Pivotal bioVenture, Alibaba DAMO Academy, Anjieming, Aoruiji, Boson Quantum, Bohe Innovation Center, Deneng Medicine, Dongmai Medical, Enshe Family Office, Fanzhuo Group, Fuxin Sci-Tech Innovation, Gerui, Guotai Junan, He Eye Specialist Hospital, Hengxu Capital, Hunan Provincial Medical Device Industrial Park, Huamei Haolian, Huimei Digital Technology, Health Road, Jieshi Medical, JD Health, Jinghan New Materials, Legend Star, Linsheng Polymer, Lulutong Health, Lide Health, Mijian, Naiterui, Ping An Good Doctor, Puchuang Medical, Ruisen Medical, Shangyong Technology, Taozi Health, Tonghe Litai, Tupai Medical, Weimei Health, Xiyi Medicine, Xikang Cloud Hospital, Xinhong Electronics, Yanyin Technology, Yishu Health, Yijiada Medical, Zhejiang Kayi, Knowledge Matrix, Jones Lang LaSalle, Suzhou Alumni Association of China Pharmaceutical University, Zhongrui Pharmaceutical Business School
Supporting Organizations for the Ranking:Proxima Ventures, Boyuan Capital, Bencao Capital, Changfa Group, Chende Capital, Changling Capital, Daotong Investment, Panlin Capital, Danlu Capital, GTJA Investment, Sequoia China, Honghui Fund, Huagai Capital, Legend Capital, Matrix Partners China, Lenovo Star, Qingsong Capital, Qiming Venture Partners, Shenzhen Capital Group, Shanghai Industrial Capital, Xianfeng Qiyun, Sunshine Ronghui Capital, Yuanhe Origin, Yuansheng Venture Capital, Yuanyi Capital
Supported Parks:Changping Life Valley Industrial Base, Optics Valley Bio-City/Wuhan Hi-Tech Medical Device Park, Haicheng Digital Medical Industry Park, Jiangsu Medical Device Technology Industrial Park, Shanghai Free Trade Zone No. 1 Life Science and Technology Industrial Park, Guangdong-Hong Kong-Macao Greater Bay Area Biosafety Innovation Port, Zhongguancun (Tongzhou) Innovative Medical Translation Industrial Park (Yifang Health Valley)
Exhibition Support Media:21st Century Business Herald, E-Pharma Academy, MedWorld Device World, Bioon Valley, TouchBio, Cyzone, Great Health Pie, Haodeya, Huihui Yaoka, Jixiao 361, Jiankangjie, Quick Doctor Ask, Bioon, Seller of Medical Devices, Taidu TIMEDOO, Tansi Bio, Investment Circle, Sina Medicine, Xiaofanzhuo, Information Hero, Yao Fangzhou, Yaokahui, Yaozhi.com, Yaopeng Xieyou, Yi Gong Xueren, Yi Qianyan, Medical World, Pharmaceutical Manager, PharmaCube, Zhiyi Xun